Abstract:Previous investigations have demonstrated that endogenous inhibitors of nitric oxide synthase (NOS), such as asymmetric dimethylarginine (ADMA), contribute importantly to endothelial dysfunction, and that fenofibrate has a protective effect on the endothelium in rats treated with low-density lipoprotein (LDL) by reducing ADMA levels. In the present study, we explored further the possible mechanism underlying inhibition of ADMA generation by fenofibrate in cultured human umbilical vein endothelial cells (HUVECs). Endothelial injury was induced in cultured HUVECs by incubation with oxidative LDL (ox-LDL) and the levels of ADMA, lactate dehydrogenase (LDH), NO and tumour necrosis factor-alpha (TNF-alpha) in the conditioned medium were measured. Cell viability and the activity of dimethylarginine dimethylaminohydrolase (DDAH) and nuclear factor-kappa B (NF-kappa B) in the cultured HUVECs were also determined. Incubation of HUVECs with ox-LDL (100 mu g/ml) for 24 h markedly elevated ADMA, LDH and TNF-alpha in the conditioned medium and significantly 886, a specific peroxisome proliferator-activated receptor-a (PPAR alpha) antagonist. The present results suggest that feno-fibrate inhibits ox-LDL-induced endothelial cell damage by decreasing ADMA and increasing DDAH activity, and the protective effects of fenofibrate on endothelial cells may be related to reduction of NF-kappa B activity by activation of the PPARa receptor.increased the activity of NF-kappa B, concomitantly with a significant decrease in the activity of DDAH and the content of NO. Pretreatment with fenofibrate ( 3, 10 or 30 mu M) significantly inhibited the increases in ADMA, LDH and TNF-alpha, attenuated the decreased levels of NO and the decreased activity of DDAH and prevented the activation of NF-kappa B. Similar effects were observed in the presence of pyrrolidine dithiocarbamate (PDTC, 10 mu M), an antagonist of NF-kappa B. The beneficial effects of fenofibrate on cultured endothelial cells were abolished by MK-886, a specific peroxisome proliferator-activated receptor-a (PPAR alpha) antagonist. The present results suggest that feno-fibrate inhibits ox-LDL-induced endothelial cell damage by decreasing ADMA and increasing DDAH activity, and the protective effects of fenofibrate on endothelial cells may be related to reduction of NF-kappa B activity by activation of the PPARa receptor.

Fenofibrate Reduces Tumor Necrosis Factor-Α Serum Concentration and Adipocyte Secretion of Hypercholesterolemic Rabbits

The Effects of Fenofibrate to Aortic Atherosclerotic Area and Serum Tumor Necrosis Factor-a in the Cholesterol-Fed Rabbits

Fenofibrate Inhibits Thrombogenic and Fibrinolytic Factors Expression in Adipose Tissue of Atherosclerotic Rabbits.

Effect of atorvastatin on tumor necrosis factor α serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits

PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats]

Fenofibrate Inhibits Thrombogenic and Fibrinolytic Factors Expression in Cultured Adipocytes from Rabbits

Pioglitazone Reduces Tumor Necrosis Factor-Α Serum Concentration and Mrna Expression of Adipose Tissue in Hypercholesterolemic Rabbits

Fenofibrate Enhances Cd36 Mediated Endocytic Uptake and Degradation of Oxidized Low Density Lipoprotein in Adipocytes from Hypercholesterolemia Rabbit

Fenofibrate Inhibits Tumor Necrosis Factor-Alpha-induced Expression of CD40 and Matrix Metalloproteinase in Human Vascular Endothelial Cells.

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia

Effects of Atorvastain on Tumor Necrosis Factor-Alpha and Tissue Factor in Atherosclerotic Rabbits

Fenofibrate Decreases Asymmetric Dimethylarginine Level in Cultured Endothelial Cells by Inhibiting NF-κB Activity

Study on the Mechanism of Fenofibrate-Inhibited Expression of Plasminogen Activator Inhibitor-1 in Adipose Tissue from Cholesterol-Fed Rabbits

Effect of Fenofibrate on LDL-induced Endothelial Dysfunction in Rats

Effect of Fenofibrate on Adiponectin Gene Expression and Endothelial Function in Diabetic Rats

Fenofibrate Reduces Serum Retinol-Binding Protein-4 by Suppressing Its Expression in Adipose Tissue

Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis

Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats

Effects of atorvastatin on the expression of tissue factor in adipose tissues and adipocytes

Fenofibrate Ameliorated Systemic and Retinal Inflammation and Modulated Gut Microbiota in High-Fat Diet-Induced Mice

Atorvastatin Reduces Tissue Factor Expression in Adipose Tissue of Atherosclerotic Rabbits.